[1]闵锐,潘真,李雨.急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二[J].国际放射医学核医学杂志,2005,29(6):272-278.
　MIN Rui,PAN Zhen,LI Yu.Degree and therapy of acute radiation syndromes——Introduction of a suggestion on acute radiation sickness therapy made by strategic national stockpile radiation working group of USA. Part 2[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):272-278.
点击复制

急性放射病的分度和治疗——介绍美国国家战略储备辐射工作组关于急性放射病治疗的建议之二(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第6期
页码:
272-278
栏目:
放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
Degree and therapy of acute radiation syndromes——Introduction of a suggestion on acute radiation sickness therapy made by strategic national stockpile radiation working group of USA. Part 2
作者:
闵锐;  潘真;  李雨
200433 上海, 第二军医大学海军医学系放射医学教研室
Author(s):
MIN Rui;  PAN Zhen;  LI Yu
Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China
关键词:
急性放射病; 治疗; 心理支持; 甲状腺
Keywords:
acute radiation syndrome; therapy; psychosocial support; thyroid
分类号:
R818.05
摘要:
根据受照剂量和生理反应所制定的造血综合征治疗方案包括造血因子治疗、输血以及选择病例的干细胞移植。其他医学治疗措施根据临床征兆和症状的发展而定,包括使用抗生素(奎诺酮,抗滤过性病原体治疗和抗真菌制剂),止吐剂和止痛剂。由于辐射造成的强烈的心理冲击,无论照射剂量多大,对于那些受照者以及家属和朋友都要给予社会心理支持。孕妇的医学处理必须考虑对胎儿的危害。在涉及放射性碘的恐怖袭击和偶然事故中,预防照射引起的甲状腺恶性病变的措施也包括在建议之中,儿童和青少年更是重点预防对象。
Abstract:
Recommendations based on radiation dose and physiologic response are made for treatment of the hematopoietic syndrome. Therapy includes treatment with hematopoietic cytokines, blood transfusion, and stem-cell transplantation in selected cases. Additional medical management based on the evolution of clinical signs and symptoms includes the use of antimicrobial agents (quinolones, antiviral therapy, and antifungal agents), antiemetic agents, and analgesic agents. Because of the strong psychological impact of a possible radiation exposure, psychosocial support will be required for those exposed, regardless of the dose, as well as for family and friends. Treatment of pregnant women must account for risk to the fetus. For terrorist or accidental events involving exposure to radioiodines, prophylaxis against malignant disease of the thyroid is also recommended, particularly for children and adolescents.

参考文献/References:

1 Bedell C. Pegfilgrastim for chemotherapy-induced neutropenia[J].Clin J Oncol Nurs, 2003, 7(1):55-56.
2 Holmes FA, O’Shaughnessy JA, Vukelja S, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage Ⅱ or stage Ⅲ/Ⅳ breast cancer[J]. J Clin Oncol, 2002, 20(3):727-731.
3 Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions[J]. JAMA, 2003, 289(15):1941-1949.
4 Blajchman MA. Immunomodulation and blood transfusion[J]. Am J Ther, 2002, 9(5):389-395.
5 Maekawa K. Overview of medical care for highly exposed victims in the Tokaimura accident[A]. Ricks RC, Berger ME, O’Hara FM, eds.The Medical Basis for Radiation Accident Preparedness:The Clinical Care of Victims[C]. New York:Parthenon, 2002.313-318.
6 Fliedner TM, Graessle D, Reimers K, et al. Stem cell transplantation in radiation accidents[A]. Medical Aspects of Radiation Emergency:The Criticality Accident in Tokaimura. Chiba[C]. Japan:National Institute of Radiological Sciences, 2000. 228-235.
7 Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer[J].Clin Infect Dis, 2002, 34(6):730-751.
8 Hughes WT. Use of antimicrobial agents for treatment of infection in the neutropenic immunocompromised patient[A]. Ricks RC, Berger ME, O’Hara FM, et al. The Medical Basis for Radiation-Accident Preparedness. The Clinical Care of Victims[C]. Washington DC:Parthenon, 2002. 117-129.
9 Brook I, Elliott TB, Ledney GD, et al. Management of postirradiation sepsis[J]. Mil Med, 2002, 167(2 suppl):105-106.
10 National council on Radiation Protection and Measurements.Management of Terrorist Events Involving Radioactive Material.NCRP Report No. 138[C]. Bethesda, MD, 2001. 125-134.
11 U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Guidance:Potassium iodide as a thyroid blocking agent in radiation emergencies. December 2001. www.fda.gov/cder/guidance/4825fnl.pdf.

相似文献/References:

[1]刘斌,潘明志.BRAF基因突变对甲状腺乳头状癌诊治价值的研究进展[J].国际放射医学核医学杂志,2015,39(2):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
　Liu Bin,Pan Mingzhi.Advances in value of BRAF gene mutation on the diagnosis and treatment of papillary thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):154.[doi:10.3760/cma.j.issn.1673-4114.2015.02.011]
[2]逯秀玲,姜恩海,孙菲菲,等.《外照射急性放射病护理规范》解读[J].国际放射医学核医学杂志,2012,36(4):231.[doi:10.3760/cma.j.issn.1673-4114.2012.04.009]
　LU Xiu-ling,JIANG En-hai,SUN Fei-fei,et al.Explanation of Nurse Standard of External Exposure Acute Radiation Sickness[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):231.[doi:10.3760/cma.j.issn.1673-4114.2012.04.009]
[3]孙文钊,张良安.硼中子俘获治疗的微剂量学研究现状[J].国际放射医学核医学杂志,2007,31(1):61.
　SUN Wen-zhao,ZHANG Liang-an.The current status of the microdosimetry study of boron neutron capture therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):61.
[4]胡锴勋,艾辉胜.极重度骨髓型与肠型急性放射病的救治进展[J].国际放射医学核医学杂志,2006,30(1):56.
　HU Kai-xun,AI Hui-sheng.The progress in treatment of severe hematopoietic and intestinal form of acute radiation syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):56.
[5]范我.用于肿瘤治疗的放射性药物[J].国际放射医学核医学杂志,2004,28(1):21.
　FAN Wo.Radiopharmaceuticals for tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):21.
[6]赵德善.放射性核素标记生长抑素类似物在淋巴瘤中的应用[J].国际放射医学核医学杂志,2004,28(5):206.
　ZHAO De-shan.The role of radionuclide-labeled somatostatin analogues in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):206.
[7]温俊,郑春兰,李顺英.红外线在医学中的应用[J].国际放射医学核医学杂志,2004,28(5):237.
　WEN Jun,ZHENG Chun-lan,LI Shun-ying.The application of infrared radiation in medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):237.
[8]陈肖华,毛秉智.日本东海村核转化工厂临界事故及应急医学处理[J].国际放射医学核医学杂志,2003,27(1):28.
　CHEN Xiao-hua,MAO Bing-zhi.The criticality accident in Tokaimura and medical aspects of radiation emergency[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):28.
[9]陈肖华,毛秉智,张军权.日本东海村核转化工厂临界事故:患者A的临床综合治疗[J].国际放射医学核医学杂志,2003,27(1):31.
　CHEN Xiao-hua,MAO Bing-zhi,ZHANG Jun-quan.Clinical management of patient A of the criticality accident in Tokaimura Japan[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):31.
[10]陈肖华,毛秉智,张军权.日本东海村核转化工厂临界事故:患者B、C的临床综合治疗[J].国际放射医学核医学杂志,2003,27(1):35.
　CHEN Xiao-hua,MAO Bing-zhi,ZHANG Jun-quan.Clinical management of patient B and C of the criticality accident in Tokaimura Japan[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):35.
[11]叶根耀.核辐射事故的医学处理新进展[J].国际放射医学核医学杂志,2003,27(3):123.
　YE Gen-yao.The recent advance in the medical handling of radiation accidents[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):123.
[12]王欣茹,罗庆良,王宝勤,等.中子急性放射病的特点及治疗研究进展[J].国际放射医学核医学杂志,2003,27(4):178.
　WANG Xin-ru,LUO Qing-liang,WANG Bao-qing,et al.The characters and developments of therapy and research of neutron-induced acute radiation sickness[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(6):178.

备注/Memo

备注/Memo:
收稿日期:2005-04-07。
更新日期/Last Update: 1900-01-01